IT9020144A0 - Composizione farmaceutica contenente egf - Google Patents

Composizione farmaceutica contenente egf

Info

Publication number
IT9020144A0
IT9020144A0 IT9020144A IT2014490A IT9020144A0 IT 9020144 A0 IT9020144 A0 IT 9020144A0 IT 9020144 A IT9020144 A IT 9020144A IT 2014490 A IT2014490 A IT 2014490A IT 9020144 A0 IT9020144 A0 IT 9020144A0
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
composition containing
containing egf
egf
pharmaceutical
Prior art date
Application number
IT9020144A
Other languages
English (en)
Other versions
IT1240683B (it
IT9020144A1 (it
Inventor
Angelo Carenzi
Gianni Pezzoli
Sante Ricciardi
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to IT20144A priority Critical patent/IT1240683B/it
Publication of IT9020144A0 publication Critical patent/IT9020144A0/it
Priority to DE69129563T priority patent/DE69129563T2/de
Priority to EP91106438A priority patent/EP0454026B1/en
Priority to AT91106438T priority patent/ATE167060T1/de
Priority to ES91106438T priority patent/ES2118726T3/es
Priority to US07/690,670 priority patent/US5200396A/en
Publication of IT9020144A1 publication Critical patent/IT9020144A1/it
Application granted granted Critical
Publication of IT1240683B publication Critical patent/IT1240683B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT20144A 1990-04-26 1990-04-26 Composizione farmaceutica contenente egf IT1240683B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT20144A IT1240683B (it) 1990-04-26 1990-04-26 Composizione farmaceutica contenente egf
DE69129563T DE69129563T2 (de) 1990-04-26 1991-04-22 Epidermis-Wachstumsfaktor als Arzneimittel zur Wiederherstellung der Neuronen der Substantia nigra in der Behandlung nervenzerstörender Störungen
EP91106438A EP0454026B1 (en) 1990-04-26 1991-04-22 Epidermal growth factor as a medicament for the restoration of neurons of the substantia nigra in the treatment of neurodegenerative disorders
AT91106438T ATE167060T1 (de) 1990-04-26 1991-04-22 Epidermis-wachstumsfaktor als arzneimittel zur wiederherstellung der neuronen der substantia nigra in der behandlung nervenzerstörender störungen
ES91106438T ES2118726T3 (es) 1990-04-26 1991-04-22 Factor de crecimiento epidermal como medicamento para la restauracion de neuronas de la substantia nigra en el tratamiento de trastornos neurodegenerativos.
US07/690,670 US5200396A (en) 1990-04-26 1991-04-24 Method of treating neurodegenerative disorders using epidermal growth factor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20144A IT1240683B (it) 1990-04-26 1990-04-26 Composizione farmaceutica contenente egf

Publications (3)

Publication Number Publication Date
IT9020144A0 true IT9020144A0 (it) 1990-04-26
IT9020144A1 IT9020144A1 (it) 1991-10-26
IT1240683B IT1240683B (it) 1993-12-17

Family

ID=11164158

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20144A IT1240683B (it) 1990-04-26 1990-04-26 Composizione farmaceutica contenente egf

Country Status (6)

Country Link
US (1) US5200396A (it)
EP (1) EP0454026B1 (it)
AT (1) ATE167060T1 (it)
DE (1) DE69129563T2 (it)
ES (1) ES2118726T3 (it)
IT (1) IT1240683B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4237047A1 (en) * 1991-11-04 1993-05-06 I N R O Handels-Gmbh, 8750 Aschaffenburg, De Drug contg. polypeptide homologous to nerve growth factor and slow virus sequence - for treating amyotrophic lateral sclerosis, spinal muscle atrophy or Parkinson's disease
FR2684301B1 (fr) * 1991-12-02 1995-03-24 Synthelabo Composition pharmaceutique contenant de l'egf pour le traitement des pathologies bronchopulmonaires.
WO1994009371A1 (en) * 1992-10-09 1994-04-28 Massachusetts Institute Of Technology Antemortem diagnostic test for alzheimer's disease
DK0728194T3 (da) * 1993-11-09 2003-04-22 Neurospheres Holdings Ltd In situ modifikation og manipulation af stamceller fra centralnervesystemet.
EP0743066A3 (en) * 1995-05-16 1998-09-30 Mitsui Pharmaceuticals, Inc. Wound-healing agent
WO2002102319A2 (en) * 2001-06-14 2002-12-27 Bristol-Myers Squibb Company Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, bgs-8, expressed highly in immune tissue
KR100628024B1 (ko) * 2002-07-03 2006-09-26 (주)넥스젠 식물에서 상피세포재생인자 및 인간 혈청 알부민을포함하는 융합 폴리펩타이드의 생산 방법
ES2304818B1 (es) * 2005-05-23 2009-10-26 Universidad Del Pais Vasco Metodos para el diagnostico y pronostico de las enfermedades desmielinizantes y para el desarrollo de medicamentos contra las enfermedades desmielinizantes.
CN101897953B (zh) * 2009-05-27 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 无创性高穿透性表皮生长因子及其应用
US10555911B2 (en) 2012-05-04 2020-02-11 Yale University Highly penetrative nanocarriers for treatment of CNS disease
CN103204920A (zh) * 2013-04-28 2013-07-17 中国人民解放军军事医学科学院毒物药物研究所 一种新型表皮生长因子及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE38892B1 (en) * 1973-03-28 1978-06-21 Ici Ltd Pharmaceutical compositions
JPH0611709B2 (ja) * 1984-10-19 1994-02-16 チロン コーポレイション 角膜基質創傷の治療のための組成物
NZ222413A (en) * 1986-11-05 1991-06-25 Ethicon Inc Compositions containing a polypeptide growth factor and a water-soluble cellulose polymer stabiliser
CA1322714C (en) * 1986-11-14 1993-10-05 Harry N. Antoniades Wound healing and bone regeneration
US5057494A (en) * 1988-08-03 1991-10-15 Ethicon, Inc. Method for preventing tissue damage after an ischemic episode
US5036046A (en) * 1988-10-12 1991-07-30 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
EP0465588A4 (en) * 1989-04-04 1992-06-03 Alcon Laboratories Inc The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions
JP3187410B2 (ja) * 1989-08-10 2001-07-11 住友製薬株式会社 脳内投与用徐放性製剤

Also Published As

Publication number Publication date
EP0454026B1 (en) 1998-06-10
ATE167060T1 (de) 1998-06-15
DE69129563D1 (de) 1998-07-16
IT1240683B (it) 1993-12-17
DE69129563T2 (de) 1999-01-07
IT9020144A1 (it) 1991-10-26
EP0454026A1 (en) 1991-10-30
ES2118726T3 (es) 1998-10-01
US5200396A (en) 1993-04-06

Similar Documents

Publication Publication Date Title
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A (fi) Farmaseuttinen ainekoostumus
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
DE69313134D1 (de) Adjuvantien enthaltende impfstoffzusammensetzung
DE69115359D1 (de) Glaszusammensetzung
DE69325158T2 (de) Photokromische Zusammensetzung
ITRM910952A0 (it) Composizioni farmaceutiche contenenti gonadotropine
MX9200622A (es) Composicion farmaceutica
IT9020144A0 (it) Composizione farmaceutica contenente egf
UA26064A1 (uk) Фармацевтичhа композиція
BR9103183A (pt) Composicao desodorante
BR9100459A (pt) Composicao
BR9006563A (pt) Composicoes fotocuraveis contendo uretano
BR9100362A (pt) Composicao antiperspirante
DE69122478D1 (de) Feste zusammensetzung
DE69217904D1 (de) Zusammensetzung
BR9103734A (pt) Composicoes
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
DE69225266D1 (de) Bis-bibenzimidazol Zusammensetzung
BR9202742A (pt) Composicao delimpeza
DE69130639D1 (de) Einzel-flüssigkeit zusammensetzung
FI925175A0 (fi) Kompositioner haerdbara medelst straolning
NO924484D0 (no) Pesticid sammensetning
FI922185A (fi) Faergframkallande komposition
IT9022456A0 (it) Composizione sterilizzante

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970311